Journal Mobile Options
Table of Contents
Vol. 11, No. 2, 2000
Issue release date: March–April 2000
Dement Geriatr Cogn Disord 2000;11:59–65
(DOI:10.1159/000017215)

Neuropathological Substrates of Dementia and Depression in Vascular Dementia, with a Particular Focus on Cases with Small Infarct Volumes

Ballard C. · McKeith I. · O’Brien J. · Kalaria R. · Jaros E. · Ince P. · Perry R.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

The neuropathological substrates of dementia and depression were evaluated in 30 patients with cerebrovascular disease and significant cognitive impairment (VaD), with a particular focus on patients with small infarct volumes (<15 ml). VaD patients with small infarct volumes had a similar degree of cognitive impairment to those with larger infarct volumes (>15 ml) but were significantly more likely to be depressed and to have areas of microinfarction. A review of individual cases with small infarct volumes suggested that the combination of microinfarction, diffuse white matter disease and perivascular changes, or the overlap of neurodegenerative pathologies and microvascular changes were particularly important. Microinfarction was also significantly associated with major depression.

Copyright © 2000 S. Karger AG, Basel



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Rocca WA, Hofman A, Brayne C, Breteler MMB, Clarke M, Copeland JRM: The prevalence of vascular dementia in Europe: Facts and fragments from 1980–1990 studies. EURO DERM B Prevalence Research Group. Ann Neurol 1991;36:817–824.
  2. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR: Brain infarction and the clinical expression of Alzheimer’s disease: The nun study. JAMA 1997;277:813–817.
  3. Heyman A, Fillenbaum G, Welsh-Bohmer KA, Gearing M, Mirra SS, Mohs RC, Peterson BL, Pieper CF: Cerebral infarcts in patients with autopsy-proven Alzheimer’s disease. CERAD. XVIII. Neurology 1998;51:159–162.
  4. Tomlinson B, Blessed G, Roth M: Observations on the brains of demented old people. J Neurol Sci 1970;11:205–242.
  5. Meilke R, Herholz K, Grond M, Kessler J, Heiss HD: Severity of vacular dementia is related to volume of metabolically impaired tissue. Arch Neurol 1992;49:909–913.
  6. Pasquier F, Leys D: Why are stroke patients prone to develop dementia. J Neurol 1997;135:135–142.

    External Resources

  7. Esiri M, Wilcock GK, Morris JH: Neuropathological assessment of the lesions of significance in vacular dementia. J Neurol Neurosurg Psychiatry 1997;63:749–753.
  8. Brun A: Pathology and pathophysiology of cerebrovascular dementia: Pure subgroups of obstructive and hypoperfusive aetiology. Dementia 1994;5:145–147.

    External Resources

  9. Liu CK, Miller BL, Cummings JL, Mehringer CM, Goldgerg MA, Howng SL, Benson DF: A quantitative MRI study of vascular dementia. Neurology 1992;42:138–143.
  10. Leys D, Hénon H, Pasquier F: White matter changes and post stroke dementia. Dementia 1998;9:25–29.
  11. Tatemichi TK, Desmond D, Prohovnik I, Cross DT, Gropen TI, Mohr JP, Stern Y: Confusion and memory loss from capsular gene infarction: A thalamocortical disconnection syndrome? Neurology 1992;42:1966–1979.
  12. Hachinski VC, Ilief LD, Zilhka E, Zilhka E, Du Boulay DH, McAllister VL, Marshall J, Russell RWR, Symon L: Cerebral blood flow in dementia. Arch Neurol 1975;32:632–637.
  13. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R: Criteria for the diagnosis of ischemic vascular dementia proposed by the state of California Alzheimer’s disease diagnostic and treatment centres. Neurology 1992;42:473–480.
  14. Ballard C, Bannister C, Solis M, Oyebode F, Wilcock G: The prevalence, associations and symptoms of depression amongst dementia sufferers. J Affect Disord 1996;36:135–144.

    External Resources

  15. Greenwald BS, Kramer-Ginsberg E, Marin DB, Laitman LB, Hermann CK, Mohs RC: Dementia with co-existent major depression. Am J Psychiatry 1989;146:1472–1478.

    External Resources

  16. Cummings JL, Miller B, Hill MA, Neshkes R: Neuropsychiatric aspects of multi-infarct dementia and Alzheimer’s disease. Arch Neurol 1987;44:389–393.
  17. Starkstein SE, Robinson RG, Price TR: Comparison of cortical and subcortical lesions in the production of post stroke mood disorders. Brain 1987;10:1045–1059.
  18. O’Brien J, Ames D, Schweitzer I: White matter changes in depression and Alzheimer’s disease: A review of magnetic resonance imaging studies. Int J Geriatr Psychiatry 1996;11:681–694.

    External Resources

  19. Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181–184.
  20. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, ed 3, rev. Washington, American Psychiatric Association, 1987.
  21. Burns A, Jacoby R, Levy R: Psychiatric phenomena in Alzheimer’s disease. I: Disorders of thought content. II: Disorders of perception. Br J Psychiatry 1990;157:72–81.
  22. Tinnetti ME: Performance orientated assessment of mobility problems in elderly patients. J Am Geriatr Soc 1986;34:119–126.
  23. Hodgkinson HM: Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing 1972;1:233–238.
  24. McKhann G, Drachman D, Fölstein M, Katzman R, Price D, Stadlen EM: Clinical Diagnosis of Alzheimer’s Disease: Report of the NINCDS ADRDA Work Group Under the Auspices of the Department of Health and Human Services Task Forces on Alzheimer’s Disease. Neurology 198434:939–944.
  25. Roman GC, Tatemichi T, Erkinjuntti T, Cummings JL, Masden JC, Garcia JH: Vascular Dementia: Diagnostic Criteria for Research Studies. Report of the NINCDS AIRENS International Workshop. Neurology 1993;43:250–260.
  26. Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK: A clinically and pathologically distinct form of Lewy body dementia in the elderly. J Neurol Sci 1990;95:119–139.
  27. SPSS Statistical Package for the Social Sciences. Windows version, release 5.0. Chicago, SPSS Inc., 1992.
  28. O’Brien J, Ames D, Chiu E, Schweitzer I, Desmond P, Tress B: Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: Follow-up study. BMJ 1998;317:982–984.
  29. Ballard CG, Patel Y, Oyebode F, Wilcock G: A one-year follow-up study of depression in dementia sufferers. Br J Psychiatry 1996;68:287–291.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50